Vitura Health and Canada’s PharmAla form psychedelics joint venture Cortexa

Business News Australia ASX-listed medicinal cannabis company Vitura Health (ASX: VIT) has joined forces with Canada-based PharmAla Biotech (CSE: MDMA) to form a 50:50 joint venture specialising in the supply of psychedelics for research and therapeutic use in Australia. Called Cortexa, the joint venture will capitalise on the distribution and industry relationships of Vitura Health […]

Go to Source

Powered by WPeMatico